Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Thrombosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Thrombosis
    Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review - (JAMA)
    Value of Genetic Testing for Preventing Blood Clots Unproven, Study Shows - (DGNews)
    Rivaroxaban More Effective Than Enoxaparin in Reducing Symptomatic Thrombotic Events in Patients Undergoing Total Hip or Knee Replacement: Presented at EHA - (DGDispatch)
    Use of MRI Increases Efficacy of Thrombolysis in Acute Stroke Beyond the 3.5-Hour Time Window: Presented at ESC - (DGDispatch)
    Thigh-Length Graduated Compression Stockings Do Not Significantly Prevent Thromboembolism After Stroke: Presented at ESC - (DGDispatch)

    News archive

     Recent webcasts/CME - Thrombosis
      Keys to Successful Outcomes from Anticoagulant and Antiplatelet Therapy: Addressing Medication Therapy Management Issues
      Thrombotic Thrombocytopenic Purpura: The Masquerader
      Cardiovascular Series: Guidelines for Anticoagulant Therapy in the Prevention and Treatment of Venous Thromboembolism: Achieving Meaningful Quality Improvement
      Perioperative Management Strategies for the Patient Requiring Warfarin
      VTE and the Hospital Pharmacist: Implementing Optimal Management Protocols

      Webcasts/CME archive

       Recent cases - Thrombosis
        Clopidogrel Resistance "Live" - The Risk of Stent Thrombosis Should Be Evaluated Before Procedures
        Stent Angioplasty of Narrowed Portocaval Shunt in Budd Chiari Syndrome: A Case Report
        Refractory Thrombotic Thrombocytopenic Purpura Associated with Oral Contraceptives and Factor V Leiden: A Case Report
        Contrast Echocardiography for the Evaluation of Tumors and Thrombi
        Hybrid Epicardial and Endocardial Catheter Ablation in a Patient With Atrial Fibrillation and Suspicious Left Atrial Thrombus

        Cases archive
          




        my personal edition > thrombosis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Prothrombin Polymorphisms Implicated in Deep Vein Thrombosis

        A DGReview of :"Prothrombin A19911G and G20210A polymorphisms' role in thrombosis"
        British Journal of Haematology

        08/14/2002
        By Anne MacLennan


        The prothrombin A19911G polymorphism may modulate the risk of the G20210A polymorphism in developing deep venous thrombosis, suggests a multicentre study in Spain.

        Although its prothrombotic role is mild, the G20210A polymorphism, which correlates with the plasmatic prothrombin levels, is the second genetic risk factor for deep venous thrombosis (DVT).

        Recently, however, a preliminary study with only a few patients and controls suggested the prothrombin A19911G polymorphism, which is also linked with slight variations of the prothrombin level, may modulate the thrombotic risk of the G20210A.

        Dr. Elena Perez-Ceballos and colleagues from the Hospital General Universitario, Murcia, and four other centres, investigated the effect of the A19911G polymorphism on the arterial and venous thrombotic risk of the prothrombin 20210G/A genotype.

        The study included 204 consecutive DVT patients and 204 matched controls.

        In addition, the team analysed 213 carriers of the 20210G/A genotype (152 with DVT, 26 with arterial thrombosis and 35 healthy subjects) and 10 homozygous 20210A/A carriers.

        A simple method was developed to determine simultaneously the genotype of both polymorphisms.

        The case control study indicated the A19911G polymorphism did not play a significant role in the development of DVT.

        Analysis of 120 20210A alleles demonstrated a complete linkage disequilibrium with the 19911 A allele. Alone or combined, these polymorphisms did not modify risk of arterial thrombosis.

        However, the 19911A/G genotype did slightly increase risk of developing DVT in carriers of the 20210G/A genotype. This indicates the prothrombin 19911 polymorphism could modulate risk of the G20210A polymorphism in developing this condition, these authors suggest.
        British Journal of Haematology Volume 118 Issue 2 Page 610 - August 2002. "Prothrombin A19911G and G20210A polymorphisms' role in thrombosis"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send